目录肽,是一种通过蛋白质降解和分析技术得到的短肽序列。是蛋白质降解过程中产生的一系列中间产物,可以代表蛋白质的结构和功能信息。目录肽的研究始于20世纪末,随着生物信息学、蛋白质组学和分子生物学技术的飞速发展,目录肽分析已成为生物科学研究的重要手段。
目录肽是指已经预先合成并标准化的肽类产品,并且有固定的序列和规格,一般有对应的CAS号。这些肽类化合物可以是自然界中存在的,也可以是人工设计的,常用于科学研究、药物开发、生物检测等领域。目录肽的优点在于它们可以直接购买使用,无需定制,节省了时间和成本。
好消息!我公司新推出一系列目录多肽。现货优惠,与国外同类产品相比,能帮您至少节省50%的科研经费。
| Product/Description | Sequence | Catalog# |
| ACTH (1-24), Human | SYSMEHFRWGKPVGKKRRPVKVYP | SL2445 |
| Angiotensins I, Human | DRVYIHPFHL | SL10322 |
| (Arg)7 | RRRRRRR | SL0735 |
| (Arg)8 | RRRRRRRR | SL08224 |
| (Arg)9 | RRRRRRRRR | SL0905 |
| B2R (54-62) | YSQVNKRYI | SL09390 |
| B8R(20-27) | TSYKFESV | SL08123 |
| Calcineurin (PP2B) Substrate | DLDVPIPGRFDRRV(pS)VAAE | SL19117 |
| CEF1, Influenza Matrix Protein M1(58-66) | GILGFVFTL | SL0962 |
| CEF4, Influenza Virus NP (342-351) | RVLSFIKGTK | SL1072 |
| CEF7, Influenza Virus NP(380-388) | ELRSRYWAI | SL09117 |
| CEF11, Epstein - Barr Virus BMLF1(280-288) | GLCTLVAML | SL0965 |
| CEF19, Epstein - Barr Virus latent NA-3A(458-466) | YPLHEQHGM | SL09121 |
| CEF20, Cytomegalovirus, CMV pp65(495-503) | NLVPMVATV | SL09122 |
| CEF21, Cytomegalovirus, CMV pp65 (417-426) | TPRVTGGGAM | SL1076 |
| CEF23, Cytomegalovirus, CMV pp65(123-131) | IPSINVHHY | SL09123 |
| CEF24, Influenza Virus PB1 Peptide(591-599) | VSDGGPNLY | SL09124 |
| CEF25, Influenza Virus NP (44 - 52) | CTELKLSDY | SL09125 |
| Cell Penetrating Peptides | rrrrrrrrr-NH2 (All D-form Arg) | SL09305 |
Derived from equine infectious anaemia virus (EIAV) envelope protein (residues 195-206) | RVEDVTNTAEYW | SL12790 |
| ESAT-6-derived Peptide (1-20) | MTEQQWNFAGIEAAASAIQG | SL20149 |
| Exendin 4 | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 | SL3901 |
| E75, Her - 2/ neu (369 - 377) | KIFGSLAFL | SL09143 |
| Flu Nucleoprotein NP (383–391) | SRYWAIRTR | SL09205 |
| F11 Receptor-Protein | (D-Lys)SVT(D-Arg)EDTGTYTC | SL13691 |
| L-4F | Ac-DWFKAFYDKVAEKFKEAF-NH2 | SL181048 |
| D-4F | Ac-dwfkafydkvaekfkeaf-NH2 (All D-form amino acids) | SL181050 |
| Sc-4F | Ac-DWFAKDYFKKAFVEEFAK-NH2 | SL182094 |
| Ghrelin (Rat) des-n-Octanoyl | G S SFLSPEHQKAQQRKESKKPPAKLQPR | SL29141 |
| Glucagon 1-29 (Bovine, Human) | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT-NH2 | SL2912 |
| GLP-1(7-36),amide,Human | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 | SL3019 |
| HA 12CA5 Epitope | YPYDVPDYA | SL09447 |
| Cys-HA 12CA5 Epitope | CYPYDVPDYA | SL1022 |
| HBcAg (HBV) (18-27) | FLPSDFFPSV | SL1027 |
| HGH Fragment 176-191 | YLRIVQCRSVEGSCGF | SL16296 |
| [Arg(Me2s)3] - Histone H4 (1-1) | SG-R(me2s)-GKGGKG | SL091213 |
| HLA-B*57-QW9 | QASQEVKNW | SL09268 |
| Human Papillomavirus (HPV) E7 Protein(49-57) | RAHYNIVTF | SL0949 |
| HXB2 gag #36/aa147-155 | ISPRTLNAW | SL091446 |
| Influenza A NP(366 - 374) Strain A/PR/8/35 | ASNENMETM | SL0964 |
| Influenza A virus M2 Protein | PIRNEWGCRCNDSSD | SL151708 |
| Influenza HA(518-526) | IYSTVASSL | SL0920 |
| Influenza NP (147-155) | TYQRTRALV | SL09321 |
| Kisspeptin - 10 (Kp-10), Metastin (110-119), Amide, Mouse, Rat | YNWNSFGLRY-NH2 | SL1066 |
| Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (33–41), LCMV GP1, gp33(33-41) | KAVYNFATC | SL09152 |
| LCMV gp33-41 | KAVYNFATM | SL09704 |
| LCMV NP396 H - 2Db Peptide | FQPQNGQFI | SL09694 |
| LL 190-201 | NEKYAQAYPNVS | SL1277 |
| LL-37, Antimicrobial Peptide, Human | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | SL3707 |
| LMP2(236-244),RRR | RRRWRRLTV | SL09111 |
| Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | SL23163 |
| α-Mating Factor Pheromone, Yeast | WHWLQLKPGQPMY | SL13258 |
| MBP (68-86), Myelin Basic Protein (68-86) | YGSLPQKSQRSQDENPV | SL17335 |
| MOG (94-108), Rat | GGYTCFFRDHSYQEE | SL151987 |
| MOG (35-55), Mouse/Rat | MEVGWYRSPFSRVVHLYRNGK | SL2134 |
| c-Myc Peptide Epitope | EQKLISEEDL | SL10394 |
| Cys-c-Myc Peptide Epitope | CEQKLISEEDL | SL1103 |
| Myosin H Chain Fragment(615-630), Mouse | Ac-SLKLMATLFSTYASAD | SL16745 |
| Myosin H Chain Fragment(614-631), Mouse | Ac-RSLKLMATLFSTYASADR | SL18151 |
| NP 381-395 | LRSRYWAIRTRSGGN | SL15768 |
| NY-ESO-1(81-88) Peptide | RGPESRLL | SL08374 |
| NY-ESO-1(157-165) | SLLMWITQC | SL09154 |
| N36, HR1, gp41 HIV Fragment | Ac-SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL-NH2 | SL3610 |
| Obestatin (Human, Monkey) | FNAPFDVGIKLSGVQYQQHSQAL-NH2 | SL2355 |
| Obestatin (Rat, Mouse) | FNAPFDVGIKLSGAQYQQHGRAL-NH2 | SL2356 |
| Obestatin (11-23) Human | LSGVQYQQHSQAL | SL13209 |
| Obestatin (11-23) Rat, Mouse | LSGAQYQQHGRAL | SL13210 |
| OVA(257-264) | SIINFEKL | SL0856 |
| OVA (323-339) | ISQAVHAAHAEINEAGR | SL1751 |
| PA1-984B Neutralizing Peptide | DYKDDDDKC | SL0921 |
| PLP (139-151) | HCLGKWLGHPDKF | SL13373 |
| [Ser140] - PLP (139-151) | HSLGKWLGHPDKF | SL13467 |
| Prion Protein (106-126) | KTNMKHMAGAAAAGAVVGGLG | SL21355 |
| Protease - Activated Receptor-2, PAR-2 Agonist | SLIGRL-NH2 | SL0617 |
| SAMS Peptide | HMRSAMSGLHLVKRR | SL1504 |
| SARS-CoV, 1203–1211 | FIAGLIAIV | SL0955 |
| SARS/S-derived Peptide-1 | RLNEVAKNL | SL0956 |
| Smcy HY Peptide (738-746) | KCSRNRQYL | SL091455 |
| Substance P | RPKPQQFFGLMC-NH2 | SL12803 |
| TAT peptide; Cell Permeable Peptides (CPP) | YGRKKRRQRRR | SL1107 |
| Tax9, HTLV-1(11-19) | LLFGYPVYV | SL09194 |
| Transdermal Peptide | ACSSSPSKHCG | SL1194 |
| Cys-T-7 Peptide | CMASMTGGQQMG | SL12330 |
| T-7 Peptide-Cys | MASMTGGQQMGC | SL12819 |
| Trp Cage | NLYIQWLKDGGPSSGRPPPS | SL201035 |
| Tag Peptides | Sequence | Catalog# |
| Flag Peptide | DYKDDDDK | SL0825 |
| Cys-Flag Peptide | CDYKDDDDK | SL09659 |
| Flg22, Flagellin Fragment | QRLSTGSRINSAKDDAAGLQIA | SL2203 |
| Triple Flag | DYKDHDGDYKDHDIDYKDDDDK | SL2212 |
| 3ÂFlag Peptide | MDYKDHDGDYKDHDIDYKDDDDK | SL2331 |
| His Tag | HHHHHH | SL0661 |
| Cys-His Tag | CHHHHHH | SL0711 |
| His Tag-Cys | HHHHHHC | SL0731 |
| Rhodopsin Epitope Tag | TETSQVAPA | SL09180 |
| V5 Epitope Tag | GKPIPNPLLGLDST | SL14516 |
| Cys-V5 Epitope Tag | CGKPIPNPLLGLDST | SL151799 |
| Histone H3 Peptides | Sequence | Catalog# |
| Histone H3 (7-14) tri-methylated Lys3 | AR-K(me3)-STGGK | SL08436 |
| Histone H3 (1-10) | ARTKQTARKS | SL1069 |
| Histone H3 (1-10) mono-methylated Lys4 | ART-K(me)-QTARKS | SL1067 |
| Histone H3 (1-10) di-methylated Lys4 | ART-K(me2)-QTARKS | SL10385 |
| Histone H3 (1-10) tri-methylated Lys4 | ART-K(me3)-QTARKS | SL1068 |
| Histone H3 (1-15) | ARTKQTARKSTGGKA | SL151785 |
| Histone H3 (1-15) mono-methylated Lys9 | ARTKQTAR-K(me)-STGGKA | SL152310 |
| Histone H3 (1-15) di-methylated Lys9 | ARTKQTAR-K(me2)-STGGKA | SL151904 |
| Histone H3 (1-15) tri-methylated Lys9 | ARTKQTAR-K(me3)-STGGKA | SL151706 |
| Histone H3 (1-15) di-methylated Lys4 | ART-K(me2)-QTARKSTGGKA | SL152121 |
| Histone H3 (1-15) tri-methylated Lys4 | ART-K(me3)-QTARKSTGGKA | SL152122 |
| Histone H3 (20-34) tri-methylated Lys8 | LATKAAR-K(me3)-SAPATGG | SL151237 |
| Histone H3 (1-19) tri-methylated Lys9,Biotin labeled | Biotin-ARTKQTAR-K(me3)-STGGKAPRKQ-NH2 | SL19405 |
| Histone H3 (1-20) | ARTKQTARKSTGGKAPRKQL | SL2050 |
| Histone H3 (1-21) | ARTKQTARKSTGGKAPRKQLA | SL21151 |
| Amyloid Peptides | Sequence | Catalog# |
| Beta-Amyloid (1-15) | DAEFRHDSGYEVHHQ | SL1505 |
| Beta-Amyloid (1-14) | DAEFRHDSGYEVHH | SL14517 |
| Beta-Amyloid (1-13) | DAEFRHDSGYEVH | SL13551 |
| Beta-Amyloid (1-12) | DAEFRHDSGYEV | SL12117 |
| Beta-Amyloid (1-11) | DAEFRHDSGYE | SL11383 |
| Beta-Amyloid (1-10) | DAEFRHDSGY | SL10654 |
| Beta-Amyloid (1-9) | DAEFRHDSG | SL09988 |
| Beta-Amyloid (1-20) | DAEFRHDSGYEVHHQKLVFF | SL20607 |
| Beta-Amyloid (1-18) | DAEFRHDSGYEVHHQKLV | SL181064 |
| Beta-Amyloid (13-22) | Ac-HHQKLVFFAE-NH2 | SL10390 |
| Beta-Amyloid (13 - 21) | Ac-HHQKLVFFA-NH2 | SL091182 |
| Beta-Amyloid (25-35) | GSNKGAIIGLM | SL11278 |
| [Ala6]-Beta-Amyloid (1-16) | DAEFRADSGYEVHHQK | SL16667 |
| EVKM-Beta-Amyloid (1-8)-Lys(Biotin) | EVKMDAEFRHDSK(Biotin) | SL13428 |
| EVKM-Beta-Amyloid (1-8) | EVKMDAEFRHDS | SL12592 |
| Gly-Lys(Biotin)-Gly-Beta-Amyloid (1-16) | GK(Biotin)GDAEFRHDSGYEVHHQK | SL19185 |
| Beta-Amyloid (3-15)-Lys(Biotin)-NH2 | EFRHDSGYEVHHQK(Biotin)-NH2 | SL14145 |
| Beta-Amyloid (1-13)-Lys(Biotin)-NH2 | DAEFRHDSGYEVHK(Biotin)-NH2 | SL14144 |
| Beta-Amyloid (1-10)-Lys(Biotin)-NH2 | DAEFRHDSGYK(Biotin)-NH2 | SL11138 |
| Beta-Amyloid (6-15)-Lys(Biotin)-NH2 | HDSGYEVHHQK(Biotin)-NH2 | SL11139 |
| Beta-Amyloid (4-15)-Lys(Biotin)-NH2 | FRHDSGYEVHHQK(Biotin)-NH2 | SL13168 |
| Beta-Amyloid (5-15)-Lys(Biotin)-NH2 | RHDSGYEVHHQK(Biotin)-NH2 | SL12179 |
| Beta-Amyloid (1-11)-Lys(Biotin)-NH2 | DAEFRHDSGYEK(biotin)-NH2 | SL12178 |
| Beta-Amyloid (1-20)-Lys(Biotin) | DAEFRHDSGYEVHHQKLVFFK(Biotin) | SL2143 |
| Beta-Amyloid (1-19)-Lys(Biotin)-NH2 | DAEFRHDSGYEVHHQKLVFK(Biotin)-NH2 | SL2078 |
| Beta-Amyloid (1-18)-Lys(Biotin)-NH2 | DAEFRHDSGYEVHHQKLVK(Biotin)-NH2 | SL1966 |
| Beta-Amyloid (1-17)-Lys(Biotin)-NH2 | DAEFRHDSGYEVHHQKLK(Biotin)-NH2 | SL1885 |
| Beta-Amyloid (1-16)-Lys(Biotin)-NH2 | DAEFRHDSGYEVHHQKK(Biotin)-NH2 | SL1764 |
| Beta-Amyloid (1-15)-Lys(Biotin)-NH2 | DAEFRHDSGYEVHHQK(Biotin)-NH2 | SL16113 |